Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Touzeau, G.
Right arrow Articles by Kato, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Touzeau, G.
Right arrow Articles by Kato, A. C.
NEUROLOGY 1983;33:317
© 1983 American Academy of Neurology

Effects of amyotrophic lateral sclerosis sera on cultured cholinergic neurons

G. Touzeau and A. C. Kato

Department of Pharmacology, Centre Medical Universtaire, Geneva, Switzerland.

Dissociated monolayer cultures of chick ciliary ganglion neurons have been used to study the effects of control and ALS sera. The cultured neurons survive and extend neurites for a minimum of 2 weeks in a standard tissue culture medium that contains 10% heat-inactivated human serum. Three parameters of the neurons have been examined when cultured in control and ALS sera for 8 to 12 days: (1) neuronal survival, (2) activity of the enzyme choline acetyltransferase, and (3) synthesis of 3H-acetylcholine using 3H-choline as precursor. ALS sera cause a small decrease in these three parameters, but this difference is not significant.

Address correspondence and reprint requests to Dr. Kato. Department of Pharmacology, Centre Medical Universitaire, 1211 Geneve 4, Switzerland.

This work was supported by the Swiss National Fund for Scientific Research (No. 3.675.0.80) and the Foundation Schmidheiny. G.T. was supported for one year by the Swiss National Fund (No 3.489.0.791 to R.W. Straub, Department of Pharmacology, University of Geneva.

Accepted for publication, July 1, 1982.




This article has been cited by other articles:


Home page
Arch NeurolHome page
S. H. Appel, S. S. Stewart, V. Appel, Y. Harati, W. Mietlowski, W. Weiss, and G. W. Belendiuk
A Double-blind Study of the Effectiveness of Cyclosporine in Amyotrophic Lateral Sclerosis
Arch Neurol, April 1, 1988; 45(4): 381 - 386.
[Abstract] [PDF]


Home page
Arch NeurolHome page
H. Mitsumoto, M. R. Hanson, and D. A. Chad
Amyotrophic Lateral Sclerosis: Recent Advances in Pathogenesis and Therapeutic Trials
Arch Neurol, February 1, 1988; 45(2): 189 - 202.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by AAN Enterprises, Inc.